These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 25801783)
1. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer. Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783 [TBL] [Abstract][Full Text] [Related]
2. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer. Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914 [TBL] [Abstract][Full Text] [Related]
3. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer. Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Zhang X; Yang X; Wang J; Liang T; Gu Y; Yang D Int J Clin Exp Pathol; 2015; 8(9):11452-7. PubMed ID: 26617874 [TBL] [Abstract][Full Text] [Related]
5. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer. Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-27b-3p via aberrant DNA methylation contributes to malignant behavior of gastric cancer cells by targeting GSPT1. Zhang C; Zou Y; Dai DQ Biomed Pharmacother; 2019 Nov; 119():109417. PubMed ID: 31539861 [TBL] [Abstract][Full Text] [Related]
7. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells. Nordström L; Andersson E; Kuci V; Gustavsson E; Holm K; Ringnér M; Guldberg P; Ek S BMC Cancer; 2015 Apr; 15():273. PubMed ID: 25880212 [TBL] [Abstract][Full Text] [Related]
9. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer. Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683 [TBL] [Abstract][Full Text] [Related]
11. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma. Qiu X; Chen J; Zhang Z; You Y; Wang Z Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636 [TBL] [Abstract][Full Text] [Related]
12. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. Otani K; Dong Y; Li X; Lu J; Zhang N; Xu L; Go MY; Ng EK; Arakawa T; Chan FK; Sung JJ; Yu J J Pathol; 2014 Nov; 234(3):302-15. PubMed ID: 24931004 [TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer. Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474 [TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo. Li X; Wu X; Li Y; Cui Y; Tian R; Singh N; Ding M; Yang Y; Gao Y Oncol Rep; 2019 Apr; 41(4):2351-2360. PubMed ID: 30720133 [TBL] [Abstract][Full Text] [Related]
15. IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells. Jin SH; Akiyama Y; Fukamachi H; Yanagihara K; Akashi T; Yuasa Y Int J Cancer; 2008 Mar; 122(5):1040-6. PubMed ID: 17957782 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation. Ling Y; Shi X; Wang Y; Ling X; Li Q Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154 [TBL] [Abstract][Full Text] [Related]
17. HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer. Sui BQ; Zhang CD; Liu JC; Wang L; Dai DQ Oncol Lett; 2018 Jun; 15(6):8833-8840. PubMed ID: 29928325 [TBL] [Abstract][Full Text] [Related]
18. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome. Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797 [TBL] [Abstract][Full Text] [Related]
19. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer. Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515 [TBL] [Abstract][Full Text] [Related]
20. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. Gopal G; Raja UM; Shirley S; Rajalekshmi KR; Rajkumar T Cancer Genet; 2013 May; 206(5):174-82. PubMed ID: 23830730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]